Stay updated on Safety & Tolerability of MRT5005 in CF Adults Clinical Trial
Sign up to get notified when there's something new on the Safety & Tolerability of MRT5005 in CF Adults Clinical Trial page.

Latest updates to the Safety & Tolerability of MRT5005 in CF Adults Clinical Trial page
- Check2 days agoChange DetectedThe page changes from a 403 error screen to the ClinicalTrials.gov record for the MRT5005 cystic fibrosis study, with its study details, eligibility criteria, outcomes, and supporting documents displayed.SummaryDifference66%

- Check9 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check23 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check30 days agoChange DetectedThe site’s footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, indicating the study record is currently not accessible.SummaryDifference20%

Stay in the know with updates to Safety & Tolerability of MRT5005 in CF Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Tolerability of MRT5005 in CF Adults Clinical Trial page.